TrialSignal transduction and targeted therapy2026

Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.